Feed Top Reports Pricing

⌘K

00:15:06·276d

SECFiling

SEC Form EFFECT filed by iCAD Inc.

ICAD· iCAD Inc.

Health Care

Original source

Companies

ICAD
iCAD Inc.
Health Care

Recent analyst ratings

Apr 17UpdateBTIG Research-
Apr 17UpdateLaidlaw-
Jan 18UpdateGuggenheim-
Jan 5UpdateOppenheimer$16.00
Nov 10UpdateJMP Securities$18.00

Related

PR185d
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
SEC269d
SEC Form 15-12G filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.
SEC276d
SEC Form EFFECT filed by iCAD Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022

SEC Form EFFECT filed by iCAD Inc. | Quantisnow